記住我
Roger V, Go A, Lloyd-Jones D, Benjamin E, Berry J, Borden W, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012; 125(1): e2–e220. DOI: https://doi.org/10.1161/CIR.0b013e31823ac046
Cresti A, García-Fernández M, Sievert H, Mazzone P, Baratta P, Solari M, et al. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. Euro Intervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2019; 15(3): e225–e30. DOI: https://doi.org/10.4244/EIJ-D-19-00128
Kuwabara M, Niwa K, Nishihara S, Nishi Y, Takahashi O, Kario K, et al. Hyperuricemia is an independent competing risk factor for atrial fibrillation. International Journal of Cardiology. 2017; 231: 137–42. DOI: https://doi.org/10.1016/j.ijcard.2016.11.268
Lin S, Lin P, Jiang H, Long Y, Chen X. Is serum total bilirubin useful to differentiate cardioembolic stroke from other stroke subtypes? Neurological Research. 2015; 37(8): 727–31. DOI: https://doi.org/10.1179/1743132815Y.0000000038
Chen S, Chung F, Chao T, Hu Y, Lin Y, Chang S, et al. A link between bilirubin levels and atrial fibrillation recurrence after catheter ablation. Journal of the Chinese Medical Association: JCMA. 2019; 82(3): 175–8. DOI: https://doi.org/10.1097/JCMA.0000000000000026
Liu Y, Wang J, Zeng W, Lyu Q. Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation. The Journal of International Medical Research. 2020; 48(10): 300060520962347. DOI: https://doi.org/10.1177/0300060520962347
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal; 2020. DOI: https://doi.org/10.1093/eurheartj/ehaa612
Zhan Y, Joza J, Al Rawahi M, Barbosa R, Samuel M, Bernier M, et al. Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation. The Canadian Journal Of Cardiology. 2018; 34(3): 252–61. DOI: https://doi.org/10.1016/j.cjca.2017.12.008
Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. European Heart Journal. 2007; 28(18): 2217–22. DOI: https://doi.org/10.1093/eurheartj/ehm356
Kapłon-Cieślicka A, Budnik M, Gawałko M, Peller M, Gorczyca I, Michalska A, et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart (British Cardiac Society). 2019; 105(17): 1310–5. DOI: https://doi.org/10.1136/heartjnl-2018-314492
Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137(2): 263–72. DOI: https://doi.org/10.1378/chest.09-1584
Uziębło-Życzkowska B, Krzesiński P, Jurek A, Kapłon-Cieślicka A, Gorczyca I, Budnik M, et al. Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation. Cardiovascular Therapeutics. 2020; 2020: 3501749. DOI: https://doi.org/10.1155/2020/3501749
Fastner C, Brachmann J, Lewalter T, Zeymer U, Sievert H, Borggrefe M, et al. Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry. Clinical research in cardiology: Official Journal of the German Cardiac Society. 2020; 109(11): 1333–41. DOI: https://doi.org/10.1007/s00392-020-01627-8
Bertaglia E, Anselmino M, Zorzi A, Russo V, Toso E, Peruzza F, et al. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world. International Journal of Cardiology. 2017; 249: 179–83. DOI: https://doi.org/10.1016/j.ijcard.2017.07.048
Ambrosy A, Vaduganathan M, Huffman M, Khan S, Kwasny M, Fought A, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. European Journal of Heart Failure. 2012; 14(3): 302–11. DOI: https://doi.org/10.1093/eurjhf/hfs007
Allen L, Felker G, Pocock S, McMurray J, Pfeffer M, Swedberg K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. European Journal of Heart Failure. 2009; 11(2): 170–7. DOI: https://doi.org/10.1093/eurjhf/hfn031
Szyguła-Jurkiewicz B, Wojnicz R, Lekston A, Duszańska A, Spinczyk B, Nowak J, et al. [Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension]. Polskie Archiwum Medycyny Wewnetrznej. 2007; 117: 227–33. DOI: https://doi.org/10.20452/pamw.138
Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World Journal of Gastroenterology. 2013; 19(38): 6398–407. DOI: https://doi.org/10.3748/wjg.v19.i38.6398
Abraham N, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radical Biology & Medicine. 2005; 39(1): 1–25. DOI: https://doi.org/10.1016/j.freeradbiomed.2005.03.010
Yaegashi T, Kato T, Usui S, Kanamori N, Furusho H, Takashima S, et al. Short-term rapid atrial pacing alters the gene expression profile of rat liver: Cardiohepatic interaction in atrial fibrillation. Heart Rhythm. 2016; 13(12): 2368–76. DOI: https://doi.org/10.1016/j.hrthm.2016.08.036
Schnabel R, Larson M, Yamamoto J, Sullivan L, Pencina M, Meigs J, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010; 121(2): 200–7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.882241
Maehama T, Okura H, Imai K, Saito K, Yamada R, Koyama T, et al. Systemic inflammation and left atrial thrombus in patients with non-rheumatic atrial fibrillation. Journal of Cardiology. 2010; 56(1): 118–24. DOI: https://doi.org/10.1016/j.jjcc.2010.03.006
Parker AM, Vilaro JR, Ahmed MM, Aranda JM. Current Management Strategies in Patients with Heart Failure and Atrial Fibrillation: A Review of the Literature. Cardiovascular Innovations and Applications. 2020; 5(2): 73–80. DOI: https://doi.org/10.15212/CVIA.2019.0595
留言 (0)